How Each Anti-Androgen Works
Anti-androgens play a crucial role in feminizing hormone therapy by reducing the effects of testosterone on your body. While estrogen alone can partially suppress testosterone, most people need an anti-androgen — particularly in the early stages of HRT — to achieve adequate suppression and optimal feminization. Spironolactone and bicalutamide work through different mechanisms, each with distinct advantages and considerations.
Spironolactone (Spiro)
Spironolactone was originally developed as a potassium-sparing diuretic for blood pressure and heart failure. Its anti-androgen properties were discovered as a side effect, and it has been used in transgender care for decades. Spiro works through multiple mechanisms: it blocks androgen receptors, preventing testosterone from binding to cells; it mildly inhibits testosterone synthesis; and its diuretic action affects fluid balance. This multi-pronged approach is effective but also explains its broader side effect profile — the diuretic effects, potassium elevation, and blood pressure changes are related to its primary pharmacological action, not just its anti-androgen properties.
Bicalutamide (Bica)
Bicalutamide is a non-steroidal androgen receptor antagonist originally developed for prostate cancer treatment. It works by competitively binding to androgen receptors, blocking testosterone and DHT from activating those receptors. Unlike spironolactone, bicalutamide does not lower serum testosterone levels — it prevents testosterone from exerting its effects at the cellular level. This means blood tests may show normal or even elevated testosterone, but the hormone cannot act on target tissues. Bicalutamide is more targeted in its action, which results in fewer off-target side effects (no diuretic effects, no potassium changes). The primary concern is a rare risk of liver toxicity, requiring regular liver function monitoring.
Head-to-Head Comparison
Here is a detailed side-by-side comparison of spironolactone and bicalutamide across all the factors that matter for your care.
| Factor | Spironolactone | Bicalutamide |
|---|---|---|
| Drug class | Potassium-sparing diuretic + anti-androgen | Non-steroidal androgen receptor antagonist |
| Mechanism | Blocks androgen receptors + mildly inhibits T synthesis + diuretic | Competitively blocks androgen receptors only |
| Typical dose | 100-200 mg/day (divided doses) | 50 mg/day (single dose) |
| Effect on serum T | Mildly reduces testosterone levels | Does not reduce serum T (may increase it) |
| Cost (without insurance) | $10-30/month | $30-80/month |
| Cost (with GoodRx/insurance) | $4-10/month | $15-40/month |
| Key monitoring | Potassium, blood pressure, kidney function | Liver function tests (ALT, AST) |
| Main side effects | Frequent urination, dizziness, high potassium, fatigue, dry skin | Rare liver toxicity, breast tenderness, fatigue |
| Evidence in trans care | Decades of use; well-studied; standard of care | Growing body of evidence; less published data in trans populations |
| FDA-approved for this use | No (off-label) | No (off-label) |
Side Effects: A Closer Look
Understanding the side effect profiles of each medication helps you and your provider make an informed choice that balances effectiveness with quality of life.
Spironolactone Side Effects
- Frequent urination: As a diuretic, spiro increases urine output — this is often the most bothersome side effect, disrupting sleep and daily activities
- Dizziness/lightheadedness: Lowered blood pressure can cause orthostatic hypotension, especially when standing quickly
- Hyperkalemia: Elevated potassium is the most clinically significant risk; requires regular monitoring, especially at doses above 100mg
- Fatigue: Many people report increased tiredness, possibly related to electrolyte shifts
- Dry skin: The diuretic effect can contribute to dehydration and skin dryness
- GI upset: Nausea, cramping, or appetite changes in some individuals
- Brain fog: Some people report cognitive dulling at higher doses
Bicalutamide Side Effects
- Hepatotoxicity (rare): The primary safety concern — liver inflammation can occur, typically within the first few months; requires regular LFT monitoring
- Breast tenderness: Gynecomastia/breast growth is a known effect — which is often desirable in feminizing HRT
- Fatigue: Some people experience tiredness, though generally milder than with spironolactone
- Hot flashes: Occasional hot flashes may occur
- No diuretic effects: Unlike spiro, bicalutamide does not cause frequent urination, dehydration, or electrolyte changes
- No blood pressure effects: No dizziness or orthostatic hypotension
- No potassium concerns: No dietary potassium restrictions needed
Many people who switch from spironolactone to bicalutamide report a significant improvement in daily quality of life — particularly the elimination of constant urination, dizziness, and fatigue. However, the liver toxicity risk with bicalutamide, while rare, is serious and necessitates diligent monitoring. Your provider will help you weigh these trade-offs based on your individual health profile, preferences, and values.
When Each Anti-Androgen May Be Preferred
The choice between spironolactone and bicalutamide depends on your health history, side effect tolerance, budget, and provider experience. Here are situations where each may be the better choice.
Spironolactone May Be Preferred When:
- You are just starting HRT and want a well-established medication
- Cost is a primary concern (significantly cheaper)
- You have healthy liver function and want to avoid liver monitoring
- You also have high blood pressure (spiro can help lower it)
- Your provider is most experienced with spironolactone
- You tolerate the diuretic side effects well
- You prefer a medication with a long track record in trans care
Bicalutamide May Be Preferred When:
- You have significant side effects from spironolactone
- Frequent urination significantly impacts your quality of life
- You have low blood pressure or are prone to dizziness
- You have kidney concerns (spiro requires adequate kidney function)
- You want to avoid potassium dietary restrictions
- You have healthy liver function and can commit to LFT monitoring
- Your provider is comfortable prescribing bicalutamide off-label
Other Anti-Androgen Options
Spironolactone and bicalutamide are the most common choices in the US, but other options exist. Here is a brief overview of alternatives your provider may discuss with you.
| Medication | Mechanism | Pros | Cons |
|---|---|---|---|
| GnRH agonists (Lupron, Supprelin) | Suppresses LH/FSH, stopping gonadal testosterone production entirely | Most effective testosterone suppression; clean mechanism | Very expensive ($500-1,500/month); injection or implant; often needs prior auth |
| Cyproterone acetate (CPA) | Progestogenic anti-androgen that suppresses gonadotropins and blocks AR | Highly effective; widely used internationally | Not FDA-approved in the US; liver toxicity risk; meningioma risk at high doses |
| High-dose estrogen monotherapy | Estrogen at sufficient levels suppresses testosterone via HPG axis feedback | No anti-androgen needed; simpler regimen | Not everyone achieves adequate T suppression; may require higher E2 doses |
| Progesterone | Mild anti-gonadotropic effect may contribute to T suppression | Additional potential benefits (mood, breast development); well-tolerated | Insufficient as sole anti-androgen; supportive role only |
There is no single "best" anti-androgen for everyone. The ideal choice depends on your health history, lifestyle, budget, side effect tolerance, and your provider's experience. What works beautifully for one person may not be the right fit for another — and that is completely okay. The goal is finding the medication that allows you to feel your best while maintaining your health and safety. Open communication with your provider is the key to finding your optimal regimen.
Frequently Asked Questions About Anti-Androgens
Spironolactone is a potassium-sparing diuretic that also blocks androgen receptors and mildly reduces testosterone production. It works through multiple mechanisms but has more side effects, particularly frequent urination, dizziness, and potassium elevation. Bicalutamide is a non-steroidal androgen receptor antagonist that blocks testosterone from activating its receptors without lowering blood testosterone levels. It is more targeted with fewer side effects but requires liver function monitoring due to a rare risk of hepatotoxicity.
Both are effective when used alongside adequate estrogen. Bicalutamide may be a more potent androgen receptor blocker, but spironolactone has a longer track record in transgender care. The overall feminization outcome depends on multiple factors, including estrogen dosing, individual genetics, and consistent medication adherence. Many providers consider them roughly equivalent in effectiveness for feminizing HRT, with the choice often coming down to side effect profiles and individual tolerance.
Common side effects include frequent urination (often the most disruptive), dizziness or lightheadedness from lowered blood pressure, elevated potassium (requires monitoring), fatigue, dry skin, and sometimes GI upset. Most side effects are dose-dependent. The potassium elevation risk is the most clinically significant — you may need to limit high-potassium foods and have regular blood tests. Many people tolerate spironolactone well at moderate doses (100mg/day), with side effects becoming more pronounced at higher doses.
The most significant concern is a rare risk of liver toxicity (hepatotoxicity), which requires regular liver function monitoring, particularly in the first 6 months. Other side effects may include breast tenderness (often desirable in feminizing HRT), mild fatigue, and occasional hot flashes. Notably, bicalutamide does not cause the diuretic effects, potassium elevation, or blood pressure changes associated with spironolactone, which many people find to be a significant quality-of-life advantage.
Yes, and many people do switch due to spironolactone side effects. Your provider will typically get baseline liver function tests, start bicalutamide, and taper spironolactone. Liver function is monitored regularly during the transition period. Hormone levels should be rechecked at 6-12 weeks after the switch. The transition is generally straightforward and well-tolerated. Communicate with your provider about your reasons for wanting to switch so they can tailor the transition plan to your needs.
Spironolactone is significantly more affordable: $10-30/month without insurance and as low as $4/month with GoodRx. Bicalutamide costs $30-80/month without insurance and $15-40/month with coverage. Both are available as generics. GnRH agonists are much more expensive at $500-1,500/month. Cost is one reason spironolactone remains the default first-line anti-androgen despite its broader side effect profile. If cost is a barrier to bicalutamide, discuss this with your provider — GoodRx coupons and manufacturer programs may help.
Yes. GnRH agonists (like leuprolide/Lupron) are the most effective testosterone suppressors but are expensive and require injections. Cyproterone acetate (CPA) is widely used internationally but is not FDA-approved in the US. High-dose estrogen monotherapy can suppress testosterone without any anti-androgen in some individuals. Progesterone may have mild anti-androgenic effects as a supporting agent. Each option has its own risk-benefit profile, and your provider can help you explore alternatives if spiro and bica are not right for you.
Not necessarily. After an orchiectomy or vaginoplasty, anti-androgens are typically no longer needed as the primary source of testosterone has been removed. Some people achieve adequate suppression with estrogen alone, particularly with injectable estradiol at sufficient doses — your provider may trial discontinuing the anti-androgen to see if estrogen monotherapy maintains suppressed testosterone levels. This should always be done with careful lab monitoring. Everyone's body and transition goals are different, so discuss long-term planning with your provider.
Personalized HRT Guidance
Every person's HRT journey is unique. Our affirming providers can help you find the right anti-androgen and overall regimen for your goals.
Talk to Our TeamReferences
- Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903. PubMed
- Neyman A, Fuqua JS, Eugster EA. Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents. J Adolesc Health. 2019;64(4):544-546. PubMed
- Angus L, Leemaqz S, Ooi O, et al. Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocr Connect. 2019;8(7):935-940. PubMed
- Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgender Health. 2022;23(S1):S1-S259. PubMed
- Deutsch MB. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. UCSF Transgender Care. 2016. UCSF
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Anti-androgen selection should be made in consultation with a qualified healthcare provider experienced in gender-affirming care. Both spironolactone and bicalutamide are used off-label for feminizing HRT. Never start, stop, or change medications without consulting your prescribing provider. Individual responses to medications vary, and your provider will tailor your treatment to your specific health profile and goals.